Atlas Trials

Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients

Clinical trial NCT01720043 · TERMINATED

Trial details

NCT number
NCT01720043
Sponsor
University of Utah
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-07-01
Primary completion
2015-04-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.